Placeholder Banner

Join us for the IP Symposium at the 2016 BIO World Congress!

April 13, 2016
Ah, San Diego. What is it they say about you?

Come for the beaches….

Stay for the fish tacos.

Here at BIO, we’ll admit it—San Diego, you have enticed us with your perpetual 65° temperatures. And it’s the perfect time to join BIO and the 1,200 attendees from 50 countries at the 2016 BIO World Congress, the world’s largest industrial biotechnology event!

But wait…THERE’S MORE?

We couldn’t be more excited to announce that BIO will be holding an Intellectual Property Symposium at World Congress, April 17-20, 2016 at the San Diego Convention Center!

The IP Symposium: “Where IP meets IB” will take place on April 20, 2016 and consist of two panels of experts who will highlight the value of intellectual property in industrial biotechnology.

You can register for World Congress here. If you’re interested in attending our IP Symposium, but cannot attend World Congress, we do have individual registration, which can be found here.

So what the heck are we going to be talking about? I’m so glad that you asked. Take a look at our IP Symposium Programming below:

BIO Logo Horizontal RGB

Assessing and Preserving Value in Biotechnology Intellectual Property

Wednesday, April 20, 2016 8:30 AM - 10:00 AM

Sponsored by Robins and Kaplan, LLP

Not all intellectual property is created equal. From IP creation, to perfection of rights, to commercialization, care must be taken to ensure that the enforceability of IP is not compromised. In this panel, our experts will provide guidance on maintaining IP value while conducting the business of using and commercializing underlying technology.

The panel will be moderated by Matthew McFarlane, Robins Kaplan LLP,and include:

  • Reena R. Desai, Synthetic Genomics, Inc.

  • David Dodds, Dodds & Associates

  • Sherry Roberg-Perez, Robins Kaplan LLP

Procuring Patents for Industrial Biotechnology Innovations

Wednesday, April 20, 2016 10:30 AM- 12:00 PM

Sponsored by Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

This panel will focus on the special challenges in securing patents in the industrial biotechnology area, primarily using 3D bioprinting and biofabrication innovations as representative examples to highlight the issues in view of recent developments in patent law.

We will provide an overview of emerging trends in industrial biotechnology innovations including the 3D bioprinting and biofabrication innovations of our panelists, and then turn to the threshold question of patent eligibility for such innovations under the current interpretations and applications of 35 USC 101. In particular, we will discuss the current status of Section 101 rejections during prosecution, and strategies to overcome or avoid the rejections such as claim drafting strategies and other patent prosecution strategies.

We will also discuss strategies to deal with other challenges that the panelists and other applicants in the industrial biotechnology areas face during patent prosecution that arise from the technology, such as enablement and written description..

Moderated by Barbara Rudolph, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, panelists include:

  • Hans Sauer, Biotechnology Innovation Organization

  • Len Smith, Heliae

  • Kai Rajan, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

So what are you waiting for? Register today, and we'll see you in San Diego!